|
Malhotra S, Hurtado-Navarro L, Pappolla A, Villar LMM, Rio J, Montalban X, Pelegrin P, Comabella M. Increased NLRP3 Inflammasome Activation and Pyroptosis in Patients With Multiple Sclerosis With Fingolimod Treatment Failure. Neurol Neuroimmunol Neuroinflamm. 2023 Mar 27;10(3):e200100. doi: 10.1212/NXI.0000000000200100. Print 2023 May. PubMed PMID: 36973075; PubMed Central PMCID: PMC10042441.
AÑO: 2023; IF: 7.8
|
36973075
|
Gil-Lianes J, Gariup G, Iranzo-Fernandez P, Mensa-Vilaro A, Penin-Franch A, Hurtado-Navarro L, Pelegrin P, Arostegui JI. Early-onset recurrent panniculitis as a phenotype of NLRC4-associated autoinflammatory syndrome: Characterization of pathogenicity of the p.Ser445Pro NLRC4 variant. Australas J Dermatol. 2023 May;64(2):260-267. doi: 10.1111/ajd.14005. Epub 2023 Feb 16. PubMed PMID: 36797819.
AÑO: 2023; IF: 2.2
|
|
Villalva M, Martinez-Garcia JJ, Jaime L, Santoyo S, Pelegrin P, Perez-Jimenez J. Polyphenols as NLRP3 inflammasome modulators in cardiometabolic diseases: a review of in vivo studies. Food Funct. 2023 Oct 30;14(21):9534-9553. doi: 10.1039/d3fo03015f. PubMed PMID: 37855750.
AÑO: 2023; IF: 5.1
|
|
Martin-Sanchez F, Penin-Franch A, Angosto-Bazarra D, Tapia-Abellan A, Compan V, Pelegrin P. Measuring NLR Oligomerization III: Detection of NLRP3 and NLRC4 Complex by Bioluminescence Resonance Energy Transfer. Methods Mol Biol. 2023;2696:93-103. doi: 10.1007/978-1-0716-3350-2_6. PubMed PMID: 37578717.
AÑO: 2023
|
|
Ionescu D, Penin-Franch A, Mensa-Vilaro A, Castillo P, Hurtado-Navarro L, Molina-Lopez C, Romero-Chala S, Plaza S, Fabregat V, Bujan S, Marques J, Casals F, Yague J, Oliva B, Fernandez-Pereira LM, Pelegrin P, Arostegui JI. First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism. Arthritis Rheumatol. 2022 Apr;74(4):692-699. doi: 10.1002/art.41999. Epub 2022 Feb 14. PubMed PMID: 34672126.
AÑO: 2022; IF: 13.3
|